ABCSX | SSGSX | ABCSX / SSGSX | |
Total Expense Ratio | 1.84 | 1.26 | 146% |
Annual Report Gross Expense Ratio | 1.84 | 1.26 | 146% |
Fund Existence | 24 years | 26 years | - |
Gain YTD | 0.665 | -2.025 | -33% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.33B | 5.5B | 42% |
Annual Yield % from dividends | 0.00 | 0.50 | - |
Returns for 1 year | -10.81 | -5.53 | 196% |
Returns for 3 years | -15.33 | -9.76 | 157% |
Returns for 5 years | 16.54 | 15.88 | 104% |
Returns for 10 years | -10.48 | 15.23 | -69% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHSCX | 46.27 | 0.61 | +1.34% |
BlackRock Health Sciences Opps Inv C | |||
OBSIX | 27.25 | -0.02 | -0.07% |
Oberweis Small-Cap Opportunities Instl | |||
ETLNX | 15.56 | -0.06 | -0.38% |
Eventide Large Cap Focus N | |||
PAHTX | 6.83 | -0.03 | -0.44% |
PGIM Jennison NextGeneration Glb Opps C | |||
SCYVX | 14.64 | -0.12 | -0.81% |
AB Small Cap Value Advisor |